회사 소개
- 법인명: Yaohai Biotechnology (Beijing) Co.,Ltd
- 등록 국가: China
- 주소: 4th Floor, Building 1, Zhongguan Science and Technology Park, No.25 Yongxing Road, Daxing District, Beijing
- 직원 수: 250 - 499
- 설립 연도: 2010
설명:
As a CRTDMO (Contract Research, Testing, Development and Manufacturing Organization) focused on microbial expression systems, Yaohai provides one-stop, end-to-end biopharmaceutical services including manufacturing recombinant proteins, peptides/polypeptides, enzymes, antibody fragments, plasmid DNA and mRNA. The company also provides long (IVT) RNA production services, operating a cGMP production platform with fermentation scale exceeding 7,500L, making it the largest GMP-level plasmid supplier in China, capable of meeting clinical and commercial needs.
사업 활동
계약 및 아웃소싱 서비스
위탁개발생산기관 (CDMO)제조업체위탁제조업체 (CMO)
천연추출물 & 생약원료
제조업체위탁제조업체 (CMO)
위탁포장 서비스
제조업체위탁제조업체 (CMO)
ATC 분류체계 (해부치료화학분류)
제조업체위탁제조업체 (CMO)
오리지널 원료의약품
제조업체위탁제조업체 (CMO)
판매 시장
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman
주요 제품/서비스
- 계약 및 아웃소싱 서비스: Biosimilars, vaccines and diagnostics CRDMO for human and veterinary use, Biological therapeutics CRDMO
- 바이오의약품: Recombinant protein/mRNA CDMO services, Novel recombinant vaccines
- 바이오의약품 서비스: Aesthetic medicine CMO / Ingredient Supply: Collagen, BTX;GLP-1 / semaglutide / Liraglutide: CMO / Ingredient Supply;Agrochemicals CMO;
당사 제품 & 서비스
Sell · Biopharmaceutical Services
인증
EU QP audited
GMP
ISO
증거
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기